Abstract
Theras-oncogene-encoded p21 protein becomes oncogenic if amino acid substitutions occur at critical positions in the polypeptide chain. The most commonly found oncogenic forms contain Val in place of Gly 12 or Leu in place of Gln 61. To determine the effects of these substitutions on the three-dimensional structure of the whole p21 protein, we have performed molecular dynamics calculations on each of these three proteins bound to GDP and magnesium ion to compute the average structures of each of the three forms. Comparisons of the computed average structures shows that both oncogenic forms with Val 12 and Leu 61 differ substantially in structure from that of the wild type (containing Gly 12 and Gln 61) in discrete regions: residues 10–16, 32–47, 55–74, 85–89, 100–110, and 119–134. All of these regions occur in exposed loops, and several of them have already been found to be involved in the cellular functioning of the p21 protein. These regions have also previously been identified as the most flexible domains of the wild-type protein and have been bound to be the same ones that differ in conformation between transforming and nontransforming p21 mutant proteins neither of which binds nucleotide. The two oncogenic forms have similar conformations in their carboxyl-terminal domains, but differ in conformation at residues 32–47 and 55–74. The former region is known to be involved in the interaction with at least three downstream effector target proteins. Thus, differences in structure between the two oncogenic proteins may reflect different relative affinities of each oncogenic protein for each of these effector targets. The latter region, 55–74, is known to be a highly mobile segment of the protein. The results strongly suggest that critical oncogenic amino acid substitutions in the p21 protein cause changes in the structures of vital domains of this protein.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Adari, H., Lowy, D. R., Willumsen, B. F., Der, C. J., and McCormick, F. (1988).Science 240, 518–521.
Almoguerra, C, Shibata, D., Forrester, K., Martin, J., Arnheim, M., and Peruchor, M. (1988)Cell 53, 813–815.
Barbacid, M. (1987)Annu. Rev. Biochem. 56, 779–827.
Baskin, L., Haspel, J., O'Driscoll, K., Ronai, Z., Friedman, F., Brandt-Rauf, P. W., Chung, D., Weinstein, I. B., Nishimura, S., Yamaizumi, Z., Singh, G., Dykes, D., Murphy, R., and Pincus, M. R. (1992).Med. Sci. Res. 20, 813–815.
Birchmeier, C., Broek, D., and Wigler, M. (1985).Cell 43, 615–621.
Chardin, P., Camonis, J. H., Gale, N. W., Van Aelst, L., Schlessinger, J., Wigier, M. H., and Bar-Sagi, D. (1993).Science 260, 1338–1343.
Chen, J., Lee, G., Murphy, R. B., Carty, R. P., Brandt-Rauf, P.W., Friedman, E., and Pincus, M. R. (1989).J. Biomol. Struct. Dynam. 6, 859–875.
Chung, D. L., Brandt-Rauf, P. W., Murphy, R. B., Nishimura, S., Yamaizumi, Z., Weinstein, I. B., and Pincus, M. R. (1991).Anticancer Res. 11, 1373–1378.
Clanton, D. J., Lu, Y., Blair, D. G., and Shih, T. Y. (1987)Mol. Cell. Biol. 1, 3092–3097.
Dauber-Osguthorpe, P., Roberts, V. A., Osguthorpe, D. J., Wolff, J., Genest, M., and Hagler, A. T. (1988).Proteins Struct. Funct. Genet. 4, 31–47.
Der, D., Finkel, T., and Cooper, G. M. (1986).Cell 44, 167–176.
Dykes, D. C., Friedman, F. K., Luster, S. M., Murphy, R. B., Brandt-Rauf, P. W., and Pincus, M. R. (1993).J. Bimol. Struct. Dynam. 11, 443–458.
Furth, M. E., Davis, L. J., Fleurdelys, B., and Scolnick, E. M. (1982).J. Virol. 43, 294–304.
Haspel, J., Dykes, D. C., Friedman, F. K., Robinson, R., Chung, D., Ronai, Z., Brandt-Rauf, P. W., Baskin, L., Weinstein, I. B., Nishimura, S., Yamaizumi, Z., Singh, G., Murphy, R. B., and Pincus, M. R. (1992).Med. Sci. Res. 20, 809–811.
Krengel, U., Schlichting, L., Scherer, A., Schumann, R., Frech, M., John, L, Kabsch, W., Pai, E. F.. and Wittinghofer, A. (1990).Cell 62, 539–548.
Lee, G., Ronai, Z. A., Pincus, M. R., Murphy, R. B., Delohery, T. M., Nishimura, S., Yamaizumi, Z., Weinstein, I. B., and Brandt-Rauf, P. W. (1990).Med. Sci. Res. 18, 771–772.
Lee, L., Ronai, Z. A., Pincus, M. R., Brandt-Rauf, P. W., Murphy, R. B., Delohery, T. M., Nishimura, S., Yamaizumi, Z., and Weinstein, I. B. (1989).Proc. Natl. Acad. Sci. USA,86, 8678–8682.
Leevers, S. J., Paterson, H. F., and Marshall, C. J. (1994).Nature 369, 411–414.
Liwo, A., Gibson, K. D., Scheraga, H. A., Brandt-Rauf, P. W., Monaco, R., and Pincus, M. R. (1994).J. Protein Chem. 13, 237–251.
Moodie, S. A., Willumsen, B. M., Weber, M. J., and Wolfman, A. (1993).Science 260, 1588–1591.
Nemethy, G., Pottle, M. S., and Scheraga, H. A. (1983).J. Phys. Chem. 87, 1883–1887.
Pai, E. F., Krengel, U., Petsko, G. A., Goody, R. S., Kabsch, W., and Wittinghofer, A. (1990).EMBO J. 9, 2351–2359.
Piela, L., and Scheraga, H. A. (1987).Biopolymers 26, S33-S58.
Pincus, M. R., and Scheraga, H. A. (1985).Acc. Chem. Res. 18, 372–379.
Pincus, M. R., van Renswoude, J., Harford, J. B., Chang, E. H., Carty, R. P., and Kalusner, R. D. (1983).Proc. Natl. Acad. Sci. USA 80, 5253–5257.
Ripoll, D., and Scheraga, H. A. (1988).Biopolymers 27, 1283–1303.
Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D., and Downward, J. (1994).Nature 370, 527–532.
Schweins, T., Geyer, M., Scheffzek, K., Warshel, A., Kalbitzer, H. R., and Wittinghofer, A. (1995).Struct. Biol. 2, 36–44.
Seeburg, P. H., Colby, W. W., Capon, D. J., Goeddel, D. V., and Levinson, A. D. (1984).Nature 312, 71–75.
Stacey, D. W., and Kung, H.-F. (1984).Nature 310, 508–511.
Trahey, M., and McCormick, F. (1987).Science 238, 542–545.
Vasquez, M., Nemethy, G., and Scheraga, H. A. (1983).Macromolecules 16, 1043–1049.
Vogel, U., Dixon, R. A. F., Schaber, M. D., Diehl, R. E., Marshall, M. S., Scolnick, E. M., Sigal, I. S., and Gibbs, J. B. (1988).Nature 335, 90–93.
Weiner, P. K., and Kollman, P. A. (1981).J. Comput. Chem. 2, 287–303.
Weiner, S. J., Kollmann, P. A., Case, D. A., Singh, U. C., Ghio, C., Alagona, G., Profeta, S., and Weiner, P. K. (1984).J. Am. Chem. Soc. 106, 765–784.
Weiner, S. J., Kollman, P. A., Nguyen, D. T., and Case, D. A. (1986).J. Comput. Chem. 7, 230–252.
Willumsen, B. M., Vass, W. C., Velu, T. J., Papageorge, A. G., Schiller, J. T., and Lowy, D. R. (1991).Mol. Cell Biol. 11, 6026–6033.
Zimmerman, S. S., Pottle, M. S., Nemethy, G., and Scheraga, H. A. (1977).Macromolecules 10, 1–9.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Monaco, R., Chen, J.M., Chung, D. et al. Comparison of the computed three-dimensional structures of oncogenic forms (bound to GDP) of theras-Gene-Encoded p21 protein with the structure of the normal (non-transforming) wild-type protein. J Protein Chem 14, 457–466 (1995). https://doi.org/10.1007/BF01888140
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01888140